259 related articles for article (PubMed ID: 23987207)
1. Association of subclinical hypothalamic-pituitary-adrenal axis suppression with bone loss in patients with asthma taking inhaled corticosteroids.
Kasayama S; Otsuki M; Tanemura M; Fujita K; Miyatake A
Ann Allergy Asthma Immunol; 2013 Sep; 111(3):229-31. PubMed ID: 23987207
[No Abstract] [Full Text] [Related]
2. Suppression of HPA axis in adults taking inhaled corticosteroids.
Greenfield JR; Samaras K
Thorax; 2006 Mar; 61(3):272-3. PubMed ID: 16517589
[No Abstract] [Full Text] [Related]
3. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children.
Zöllner EW; Lombard CJ; Galal U; Hough FS; Irusen EM; Weinberg E
Pediatrics; 2012 Dec; 130(6):e1512-9. PubMed ID: 23147980
[TBL] [Abstract][Full Text] [Related]
4. The hypothalamic-pituitary-adrenal axis in asthmatic children.
Priftis KN; Papadimitriou A; Nicolaidou P; Chrousos GP
Trends Endocrinol Metab; 2008 Jan; 19(1):32-8. PubMed ID: 18155557
[TBL] [Abstract][Full Text] [Related]
5. [The secondary effects of inhaled steroids in asthma. New prospects].
González Pérez-Yarza E; de Frutos Martínez C; Mintegui Aranburu J
Arch Bronconeumol; 1999 May; 35 Suppl 3():15-21. PubMed ID: 10410219
[No Abstract] [Full Text] [Related]
6. Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids.
Bernstein DI; Allen DB
Ann Allergy Asthma Immunol; 2007 Feb; 98(2):118-27. PubMed ID: 17304877
[TBL] [Abstract][Full Text] [Related]
7. [Adrenal effect of inhaled corticosteroids in adult asthmatic patients].
Adachi M; Minoguchi K
Nihon Kokyuki Gakkai Zasshi; 2006 Mar; 44(3):151-9. PubMed ID: 16617856
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled and nasal corticosteroids: is the early-morning serum adrenocorticotropic hormone (ACTH) a useful screening test?
Zöllner EW; Lombard C; Galal U; Hough S; Irusen E; Weinberg E
Pediatr Allergy Immunol; 2011 Sep; 22(6):614-20. PubMed ID: 21797928
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of inhaled corticosteroids (ICS) in children with asthma.
Petrisko MA; Skoner JD; Skoner DP
J Asthma; 2008; 45 Suppl 1():1-9. PubMed ID: 19093279
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2)--the risk as determined by gold standard adrenal function tests: a systematic review.
Zöllner EW
Pediatr Allergy Immunol; 2007 Sep; 18(6):469-74. PubMed ID: 17680905
[TBL] [Abstract][Full Text] [Related]
12. Addressing steroid phobia: improving the risk-benefit ratio with new agents.
Skoner JD; Schaffner TJ; Schad CA; Kwon AY; Skoner DP
Allergy Asthma Proc; 2008; 29(4):358-64. PubMed ID: 18702881
[TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroids: clinical relevance of safety measures.
Price JF
Pediatr Pulmonol Suppl; 1997 Sep; 15():40-5. PubMed ID: 9316101
[TBL] [Abstract][Full Text] [Related]
14. Long-term management of asthma in children: safety of inhaled corticosteroids.
National Asthma Education and Prevention Program
J Allergy Clin Immunol; 2002 Nov; 110(5 Suppl):S160-8. PubMed ID: 12518557
[No Abstract] [Full Text] [Related]
15. Endocrine-immune interactions in adrenal function of asthmatic children on inhaled corticosteroids.
Priftis KN; Papadimitriou A; Anthracopoulos MB; Fretzayas A; Chrousos GP
Neuroimmunomodulation; 2009; 16(5):333-9. PubMed ID: 19571594
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids: 2. Systemic toxicity.
Samraj GP; Kuritzky L
Hosp Pract (1995); 2000 Jun; 35(6):35-8. PubMed ID: 10884817
[No Abstract] [Full Text] [Related]
17. Evaluation of hypothalamic-pituitary-adrenal axis (HPA) suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid (JPEM 2006; 19: 1015-1023).
Priftis KN; Papadimitriou A; Anthracopoulos MB; Fretzayas A; Nicolaidou P
J Pediatr Endocrinol Metab; 2007 Feb; 20(2):261; author reply 261-2. PubMed ID: 17396445
[No Abstract] [Full Text] [Related]
18. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids.
Brown PH; Blundell G; Greening AP; Crompton GK
Respir Med; 1991 Nov; 85(6):501-10. PubMed ID: 1775677
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamo-pituitary-adrenal axis suppression in asthmatics.
Leitch AG
Respir Med; 1993 May; 87(4):321. PubMed ID: 9728238
[No Abstract] [Full Text] [Related]
20. The dull-edged sword of inhaled corticosteroids.
Harding SM
Chest; 1999 Oct; 116(4):854-6. PubMed ID: 10531140
[No Abstract] [Full Text] [Related]
[Next] [New Search]
